Dynamic Changes of Monocytes and NK Cells of CHC Patient Treated by DAAs

NCT03063723 · clinicaltrials.gov ↗

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C (Disorder)

Interventions

DRUG: Ledipasvir-Sofosbuvir
DRUG: Daclatasvir-Sofosbuvir

Sponsor

Third Affiliated Hospital, Sun Yat-Sen University